Accelerate Diagnostics, Inc. (AXDX)
USD 0.7
(-0.71%)
USD 0.7
(-0.71%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 56.57 Million USD | -14.42% |
| 2022 | 66.1 Million USD | -7.12% |
| 2021 | 71.17 Million USD | 4.43% |
| 2020 | 68.15 Million USD | -11.75% |
| 2019 | 77.23 Million USD | -6.78% |
| 2018 | 82.85 Million USD | 23.0% |
| 2017 | 67.35 Million USD | 0.91% |
| 2016 | 66.74 Million USD | 46.07% |
| 2015 | 45.69 Million USD | 44.44% |
| 2014 | 31.63 Million USD | 106.13% |
| 2013 | 15.34 Million USD | 327.4% |
| 2012 | 3.59 Million USD | 134.62% |
| 2011 | 1.53 Million USD | -6.32% |
| 2010 | 1.63 Million USD | -16.17% |
| 2009 | 1.94 Million USD | -11.15% |
| 2008 | 2.19 Million USD | -2.12% |
| 2007 | 2.24 Million USD | -33.61% |
| 2006 | 3.37 Million USD | 29.56% |
| 2005 | 2.6 Million USD | 42.7% |
| 2004 | 1.82 Million USD | -18.8% |
| 2003 | 2.24 Million USD | 81.48% |
| 2002 | 1.23 Million USD | -29.59% |
| 2001 | 1.75 Million USD | -45.69% |
| 2000 | 3.24 Million USD | 47.55% |
| 1999 | 2.19 Million USD | -5.2% |
| 1998 | 2.31 Million USD | 65.48% |
| 1997 | 1.4 Million USD | 133.33% |
| 1996 | 600 Thousand USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 10.87 Million USD | -4.57% |
| 2024 Q2 | 9.28 Million USD | -14.68% |
| 2023 FY | 56.57 Million USD | -14.42% |
| 2023 Q1 | 17.07 Million USD | 15.35% |
| 2023 Q3 | 14.75 Million USD | 10.26% |
| 2023 Q4 | 11.4 Million USD | -22.75% |
| 2023 Q2 | 13.38 Million USD | -21.61% |
| 2022 FY | 66.1 Million USD | -7.12% |
| 2022 Q4 | 14.8 Million USD | -4.76% |
| 2022 Q3 | 15.54 Million USD | -18.51% |
| 2022 Q1 | 16.69 Million USD | 3.75% |
| 2022 Q2 | 19.06 Million USD | 14.21% |
| 2021 Q1 | 20.92 Million USD | 28.92% |
| 2021 FY | 71.17 Million USD | 4.43% |
| 2021 Q2 | 18.64 Million USD | -10.9% |
| 2021 Q4 | 16.09 Million USD | 3.71% |
| 2021 Q3 | 15.51 Million USD | -16.76% |
| 2020 Q3 | 16.46 Million USD | -1.28% |
| 2020 Q4 | 16.23 Million USD | -1.43% |
| 2020 FY | 68.15 Million USD | -11.75% |
| 2020 Q1 | 18.78 Million USD | -5.05% |
| 2020 Q2 | 16.67 Million USD | -11.21% |
| 2019 Q2 | 18.98 Million USD | -3.41% |
| 2019 Q3 | 18.8 Million USD | -0.94% |
| 2019 Q1 | 19.65 Million USD | -3.09% |
| 2019 FY | 77.23 Million USD | -6.78% |
| 2019 Q4 | 19.78 Million USD | 5.19% |
| 2018 Q2 | 21.39 Million USD | 1.21% |
| 2018 FY | 82.85 Million USD | 23.0% |
| 2018 Q4 | 20.28 Million USD | 1.19% |
| 2018 Q3 | 20.04 Million USD | -6.29% |
| 2018 Q1 | 21.13 Million USD | 20.06% |
| 2017 Q1 | 14.81 Million USD | -7.78% |
| 2017 Q2 | 16.98 Million USD | 14.67% |
| 2017 Q3 | 17.95 Million USD | 5.68% |
| 2017 Q4 | 17.6 Million USD | -1.94% |
| 2017 FY | 67.35 Million USD | 0.91% |
| 2016 Q1 | 15.33 Million USD | 22.31% |
| 2016 Q4 | 16.06 Million USD | -7.9% |
| 2016 Q2 | 17.9 Million USD | 16.79% |
| 2016 Q3 | 17.44 Million USD | -2.62% |
| 2016 FY | 66.74 Million USD | 46.07% |
| 2015 Q3 | 11.29 Million USD | -8.04% |
| 2015 Q4 | 12.53 Million USD | 10.97% |
| 2015 FY | 45.69 Million USD | 44.44% |
| 2015 Q1 | 9.57 Million USD | 8.11% |
| 2015 Q2 | 12.28 Million USD | 28.36% |
| 2014 Q1 | 5.76 Million USD | 11.07% |
| 2014 Q4 | 8.85 Million USD | 0.12% |
| 2014 Q3 | 8.84 Million USD | 8.13% |
| 2014 FY | 31.63 Million USD | 106.13% |
| 2014 Q2 | 8.17 Million USD | 41.95% |
| 2013 Q2 | 3.78 Million USD | 47.48% |
| 2013 Q3 | 3.8 Million USD | 0.65% |
| 2013 FY | 15.34 Million USD | 327.4% |
| 2013 Q4 | 5.18 Million USD | 36.16% |
| 2013 Q1 | 2.56 Million USD | -11.52% |
| 2012 Q2 | 2.18 Million USD | 415.72% |
| 2012 Q3 | 1.35 Million USD | -38.11% |
| 2012 FY | 3.59 Million USD | 134.62% |
| 2012 Q4 | 2.9 Million USD | 114.6% |
| 2012 Q1 | 423.42 Thousand USD | 20.3% |
| 2011 FY | 1.53 Million USD | -6.32% |
| 2011 Q4 | 351.96 Thousand USD | -44.3% |
| 2011 Q2 | 378.9 Thousand USD | 1.28% |
| 2011 Q1 | 374.1 Thousand USD | 3.57% |
| 2011 Q3 | 631.91 Thousand USD | 66.78% |
| 2010 Q2 | 347.18 Thousand USD | -14.35% |
| 2010 Q4 | 361.19 Thousand USD | -13.25% |
| 2010 Q3 | 416.38 Thousand USD | 19.93% |
| 2010 FY | 1.63 Million USD | -16.17% |
| 2010 Q1 | 405.36 Thousand USD | -8.36% |
| 2009 Q4 | 442.36 Thousand USD | 0.78% |
| 2009 FY | 1.94 Million USD | -11.15% |
| 2009 Q1 | 504.27 Thousand USD | 4.75% |
| 2009 Q2 | 484.68 Thousand USD | -3.88% |
| 2009 Q3 | 438.92 Thousand USD | -9.44% |
| 2008 Q3 | 478.63 Thousand USD | -29.28% |
| 2008 Q1 | 429.22 Thousand USD | -11.62% |
| 2008 FY | 2.19 Million USD | -2.12% |
| 2008 Q4 | 481.41 Thousand USD | 0.58% |
| 2008 Q2 | 676.82 Thousand USD | 57.69% |
| 2007 Q1 | 539.14 Thousand USD | 229.9% |
| 2007 Q3 | 601.76 Thousand USD | 32.01% |
| 2007 Q2 | 455.84 Thousand USD | -15.45% |
| 2007 FY | 2.24 Million USD | -33.61% |
| 2007 Q4 | 485.68 Thousand USD | -19.29% |
| 2006 Q4 | -415.04 Thousand USD | -162.42% |
| 2006 Q3 | 664.92 Thousand USD | -9.25% |
| 2006 Q2 | 732.72 Thousand USD | -14.71% |
| 2006 Q1 | 859.11 Thousand USD | -3.57% |
| 2006 FY | 3.37 Million USD | 29.56% |
| 2005 Q2 | -1.86 Million USD | -380.46% |
| 2005 Q3 | 891.84 Thousand USD | 147.81% |
| 2005 Q1 | 665.07 Thousand USD | 16.95% |
| 2005 FY | 2.6 Million USD | 42.7% |
| 2005 Q4 | 890.9 Thousand USD | -0.1% |
| 2004 Q2 | 330.52 Thousand USD | -21.99% |
| 2004 Q4 | 568.7 Thousand USD | 3.58% |
| 2004 Q1 | 423.68 Thousand USD | -18.59% |
| 2004 Q3 | 549.05 Thousand USD | 66.12% |
| 2004 FY | 1.82 Million USD | -18.8% |
| 2003 Q2 | 860.22 Thousand USD | 71.56% |
| 2003 FY | 2.24 Million USD | 81.48% |
| 2003 Q1 | 501.4 Thousand USD | 2.23% |
| 2003 Q3 | 551.22 Thousand USD | -35.92% |
| 2003 Q4 | 520.45 Thousand USD | -5.58% |
| 2002 Q1 | 224.61 Thousand USD | -35.96% |
| 2002 FY | 1.23 Million USD | -29.59% |
| 2002 Q4 | 490.45 Thousand USD | 23.68% |
| 2002 Q3 | 396.54 Thousand USD | 8.13% |
| 2002 Q2 | 366.72 Thousand USD | 63.27% |
| 2001 Q2 | 359.89 Thousand USD | 7.5% |
| 2001 Q3 | 296.94 Thousand USD | -17.49% |
| 2001 Q4 | 350.75 Thousand USD | 18.12% |
| 2001 FY | 1.75 Million USD | -45.69% |
| 2001 Q1 | 334.77 Thousand USD | -42.26% |
| 2000 Q3 | 485.35 Thousand USD | -70.19% |
| 2000 FY | 3.24 Million USD | 47.55% |
| 2000 Q2 | 1.62 Million USD | 150.31% |
| 2000 Q1 | 650.46 Thousand USD | -14.89% |
| 2000 Q4 | 579.75 Thousand USD | 19.45% |
| 1999 FY | 2.19 Million USD | -5.2% |
| 1999 Q4 | 764.22 Thousand USD | 38.65% |
| 1999 Q3 | 551.19 Thousand USD | -11.39% |
| 1999 Q2 | 622.06 Thousand USD | 24.3% |
| 1999 Q1 | 500.47 Thousand USD | -13.62% |
| 1998 Q1 | 660.78 Thousand USD | 33.77% |
| 1998 Q4 | 579.38 Thousand USD | 17.21% |
| 1998 Q3 | 494.31 Thousand USD | -35.76% |
| 1998 FY | 2.31 Million USD | 65.48% |
| 1998 Q2 | 769.46 Thousand USD | 16.45% |
| 1997 Q1 | 400 Thousand USD | 100.0% |
| 1997 Q2 | 600 Thousand USD | 50.0% |
| 1997 Q3 | 392.49 Thousand USD | -34.59% |
| 1997 Q4 | 493.96 Thousand USD | 25.85% |
| 1997 FY | 1.4 Million USD | 133.33% |
| 1996 Q2 | -100 Thousand USD | -125.0% |
| 1996 Q3 | 200 Thousand USD | 300.0% |
| 1996 FY | 600 Thousand USD | 0.0% |
| 1996 Q4 | 200 Thousand USD | 0.0% |
| 1996 Q1 | 400 Thousand USD | 100.0% |
| 1995 Q3 | - USD | 0.0% |
| 1995 Q4 | 200 Thousand USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Acutus Medical, Inc. | 11.22 Million USD | -404.081% |
| Cerus Corporation | 143.15 Million USD | 60.478% |
| OrthoPediatrics Corp. | 137.01 Million USD | 58.708% |
| PetVivo Holdings, Inc. | 11.36 Million USD | -398.008% |
| Talis Biomedical Corporation | 67.18 Million USD | 15.789% |
| Vivos Therapeutics, Inc. | 24.94 Million USD | -126.802% |
| Inogen, Inc. | 236.08 Million USD | 76.035% |
| Spectral AI, Inc. | 20.86 Million USD | -171.175% |
| Nano-X Imaging Ltd. | 55.99 Million USD | -1.038% |
| CVRx, Inc. | 76.14 Million USD | 25.694% |
| DIH Holding US, Inc. Warrants | 3.52 Million USD | -1503.687% |
| Helius Medical Technologies, Inc. | 12.48 Million USD | -353.023% |
| Orthofix Medical Inc. | 667.42 Million USD | 91.523% |
| Venus Concept Inc. | 80.47 Million USD | 29.696% |
| Bioventus Inc. | 409.91 Million USD | 86.198% |
| BrainsWay Ltd. | 28.01 Million USD | -101.934% |
| Envoy Medical, Inc. | 17.89 Million USD | -216.114% |
| electroCore, Inc. | 32.03 Million USD | -76.635% |
| IceCure Medical Ltd | 16.87 Million USD | -235.257% |
| Lucid Diagnostics Inc. | 42.43 Million USD | -33.338% |
| Monogram Orthopaedics, Inc. | 17.63 Million USD | -220.864% |
| MaxCyte, Inc. | 84.84 Million USD | 33.316% |
| NeuroOne Medical Technologies Corporation | 12.41 Million USD | -355.842% |
| Nexalin Technology, Inc. | 5.78 Million USD | -878.629% |
| PAVmed Inc | 64.82 Million USD | 12.725% |
| Rapid Micro Biosystems, Inc. | 51.07 Million USD | -10.768% |
| RxSight, Inc. | 103.85 Million USD | 45.519% |
| Sight Sciences, Inc. | 126.44 Million USD | 55.256% |
| SI-BONE, Inc. | 156.35 Million USD | 63.813% |
| TELA Bio, Inc. | 84.18 Million USD | 32.795% |
| TriSalus Life Sciences, Inc. | 70.05 Million USD | 19.239% |
| Treace Medical Concepts, Inc. | 203.36 Million USD | 72.179% |
| LivaNova PLC | 843.54 Million USD | 93.293% |
| 908 Devices Inc. | 68.08 Million USD | 16.895% |
| Alphatec Holdings, Inc. | 483.59 Million USD | 88.301% |
| Nemaura Medical Inc. | 7.13 Million USD | -692.542% |
| NeuroPace, Inc. | 75.29 Million USD | 24.859% |
| LENSAR, Inc. | 33.33 Million USD | -69.72% |
| Apyx Medical Corporation | 51.01 Million USD | -10.898% |
| Cutera, Inc. | 197.72 Million USD | 71.385% |
| STRATA Skin Sciences, Inc. | 24.78 Million USD | -128.312% |
| BioSig Technologies, Inc. | 28.53 Million USD | -98.311% |
| Anika Therapeutics, Inc. | 191.47 Million USD | 70.451% |
| ClearPoint Neuro, Inc. | 36.06 Million USD | -56.9% |
| Integra LifeSciences Holdings Corporation | 836.39 Million USD | 93.235% |
| Axonics, Inc. | 270.2 Million USD | 79.061% |
| Outset Medical, Inc. | 198.77 Million USD | 71.536% |
| IRIDEX Corporation | 31.81 Million USD | -77.84% |
| PROCEPT BioRobotics Corporation | 180.21 Million USD | 68.606% |
| IRadimed Corporation | 30.12 Million USD | -87.824% |
| Tivic Health Systems, Inc. | 8.53 Million USD | -563.127% |
| INVO Bioscience, Inc. | 7.85 Million USD | -620.437% |
| Telesis Bio, Inc. | 63.48 Million USD | 10.885% |
| Viemed Healthcare, Inc. | 98.45 Million USD | 42.533% |
| Varex Imaging Corporation | 224.8 Million USD | 74.832% |
| Quipt Home Medical Corp. | 148.66 Million USD | 61.943% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -382.624% |
| Pulmonx Corporation | 112.68 Million USD | 49.792% |
| Dynatronics Corporation | 9.9 Million USD | -471.032% |
| Modular Medical, Inc. | 17.52 Million USD | -222.768% |
| ReShape Lifesciences Inc. | 20.18 Million USD | -180.269% |
| Semler Scientific, Inc. | 38.94 Million USD | -45.28% |
| InMode Ltd. | 215.68 Million USD | 73.768% |
| Bruker Corporation | 1.07 Billion USD | 94.744% |
| Cytosorbents Corporation | 48.33 Million USD | -17.049% |
| DexCom, Inc. | 1.69 Billion USD | 96.655% |
| Align Technology, Inc. | 2.07 Billion USD | 97.276% |
| Viveve Medical, Inc. | 22.17 Million USD | -155.166% |
| ZimVie Inc. | 275.12 Million USD | 79.436% |
| Movano Inc. | 29.69 Million USD | -90.562% |
| Cytek Biosciences, Inc. | 137.27 Million USD | 58.784% |
| Nexalin Technology, Inc. | 5.78 Million USD | -878.629% |
| DIH Holdings US, Inc. Class A Common Stock | 3.52 Million USD | -1503.687% |
| Tandem Diabetes Care, Inc. | 600.92 Million USD | 90.585% |
| Profound Medical Corp. | 33.6 Million USD | -68.371% |
| Insulet Corporation | 939.9 Million USD | 93.98% |
| enVVeno Medical Corporation | 25.23 Million USD | -124.178% |
| Surmodics, Inc. | 98.69 Million USD | 42.675% |
| iCAD, Inc. | 22.22 Million USD | -154.569% |
| Nuwellis, Inc. | 22.61 Million USD | -150.201% |
| Biotricity, Inc. | 17.18 Million USD | -229.238% |
| iRhythm Technologies, Inc. | 445.88 Million USD | 87.311% |
| Aethlon Medical, Inc. | 12.27 Million USD | -360.826% |
| InspireMD, Inc. | 22.95 Million USD | -146.527% |
| PAVmed Inc. | 64.82 Million USD | 12.725% |
| BIOLASE, Inc. | 34.66 Million USD | -63.232% |
| Beyond Air, Inc. | 61.7 Million USD | 8.301% |
| FONAR Corporation | 28.6 Million USD | -97.793% |
| AxoGen, Inc. | 149.33 Million USD | 62.114% |
| Vivani Medical, Inc. | 26.96 Million USD | -109.82% |
| Tactile Systems Technology, Inc. | 177.09 Million USD | 68.052% |
| Inari Medical, Inc. | 448.59 Million USD | 87.388% |
| UFP Technologies, Inc. | 58.08 Million USD | 2.601% |
| QT Imaging Holdings, Inc. | 4.92 Million USD | -1048.186% |
| Heart Test Laboratories, Inc. | 6.31 Million USD | -795.464% |
| Tenon Medical, Inc. | 16.96 Million USD | -233.439% |
| Autonomix Medical, Inc. Common Stock | 7.39 Million USD | -665.291% |
| Co-Diagnostics, Inc. | 44.1 Million USD | -28.286% |
| AdaptHealth Corp. | 1.07 Billion USD | 94.751% |
| Sintx Technologies, Inc. | 15.2 Million USD | -272.199% |
| NanoVibronix, Inc. | 4.97 Million USD | -1037.704% |
| Quanterix Corporation | 118.1 Million USD | 52.093% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -382.624% |
| Sensus Healthcare, Inc. | 14.44 Million USD | -291.76% |
| Pacific Biosciences of California, Inc. | 392.66 Million USD | 85.591% |
| TransMedics Group, Inc. | 182.82 Million USD | 69.053% |
| ReWalk Robotics Ltd. | 28.06 Million USD | -101.596% |
| NeuroMetrix, Inc. | 11.09 Million USD | -409.761% |
| Hyperfine, Inc. | 52.87 Million USD | -7.009% |
| Establishment Labs Holdings Inc. | 172 Million USD | 67.106% |
| Biomerica, Inc. | 6.97 Million USD | -710.805% |
| Bone Biologics Corporation | 9.42 Million USD | -500.087% |
| AVITA Medical, Inc. | 80.77 Million USD | 29.96% |
| Bluejay Diagnostics, Inc. | 10.31 Million USD | -448.703% |
| Silk Road Medical, Inc | 186.35 Million USD | 69.64% |